1. Doses of medial rectus muscle recessions for divergence insufficiency-type esotropia.
- Author
-
Miller AM, Holmes JM, Wu R, Kraker RT, Crouch ER, Lee KA, Del Monte MA, Marsh JD, Kraus CL, Wallace DK, Colburn JD, Kemp PS, and Cotter SA
- Subjects
- Humans, Male, Female, Middle Aged, Adult, Aged, Retrospective Studies, Young Adult, Suture Techniques, Diplopia physiopathology, Diplopia surgery, Adolescent, Treatment Outcome, Oculomotor Muscles surgery, Oculomotor Muscles physiopathology, Ophthalmologic Surgical Procedures methods, Esotropia surgery, Esotropia physiopathology, Vision, Binocular physiology
- Abstract
We evaluated whether doses of bilateral medial rectus recessions greater than Parks's tables yielded superior outcomes for adult-onset divergence insufficiency. Forty-two patients underwent bilateral medial rectus recessions. Dose was analyzed as the average total per muscle (surgery + suture adjustment if performed) and compared with the standard dose tables (based on preoperative distance esodeviation), as difference between dose performed and dose indicated by Parks's tables. Each participant was classified as having received either Parks's dose (within 0.5 mm) or a dose greater than Parks's dose. Success was defined as "rarely" or "never" diplopia in distance straight-ahead gaze and reading. For patients classified as success, the mean difference between actual surgical dose performed and Parks's dose was calculated. Success was 91% (29/32) in those receiving greater than Parks's dose versus 67% (6/9) with Parks's dose (difference = 24%; 95% CI, -5% to 60%). The mean surgical dose was 1.0 mm greater than Parks's tables for the 35 successes (at 10 weeks) versus 0.7 mm greater for the 6 failures (difference = 0.4 mm; 95% CI, -0.2 to 0.9). For medial rectus recessions in adult-onset divergence insufficiency-type esotropia, a surgical dose 1 mm greater than Parks's tables, for each muscle, is a reasonable strategy., (Copyright © 2024 American Association for Pediatric Ophthalmology and Strabismus. Published by Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF